Case series / case reportindependent cross-checkabstract checked I-BAR-105 standard review

Egyptian surgeon series: early safety of sleeve

Perioperative Morbidity and Mortality of Laparoscopic Sleeve Gastrectomy (LSG) in a Single-Surgeon Experience on 892 Patients Over 11 Years.

Overview

El Masry et al.. World J Surg 2023 · PMID 37548678 · DOI 10.1007/s00268-023-07123-0

2 of 892 patients died within 30 days (0.22%).

Does the study support the specific claim? Partly · Methodological quality: low

Study explained simply

What did the researchers want to find out?: Report early complications
How was the study done?: Single-surgeon series
How many people, animals or samples were studied?: 892
What was actually found?: Mortality 0.22%
How large was the observed effect?: 2/892
What do the results mean in everyday life?: Early death is uncommon
What are the study's limitations?: One surgeon, no comparison
What does it say about Elawady's specific claim?: Shows deaths occur but are rare
Do the results apply to Germany and Europe?: Egyptian practice
What can explicitly not be concluded from this study?: Long-term outcomes

Authors: El Masry et al.
Journal: World J Surg
Year: 2023
Identifier: PMID 37548678 DOI 10.1007/s00268-023-07123-0
Verification: verified – PubMed efetch 2026-10-26 + Crossref API
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: COI statement (PubMed record): The authors declare that they have no conflict of interest.

What are 30-day morbidity and mortality after laparoscopic sleeve gastrectomy in an Egyptian practice?

Study design: Case series / case report – Retrospective single-surgeon series with prospectively collected data
Population: Patients undergoing LSG by one surgeon in Cairo
Country: Egypt
Period: July 2011-August 2022
Sample size: 892
Inclusion and exclusion criteria: All LSG by the same surgeon

Results: Early adverse events 16 (1.79%); transfusion 1.35%; ICU 0.22%; reoperation 0.9% (8); mortality 0.22% (2/892). BMI, hypertension and revisional surgery predicted morbidity.
Absolute risks: 30-day mortality 2/892 (0.22%).
Authors' conclusion: Confirms short-term safety of LSG; BMI, hypertension and revisional surgery are risk factors.

2/892 = 0.22%; higher than the pooled 0.05% for sleeve (I-BAR-103), but imprecise (2 events).

Regional (Egyptian) estimate of early mortality after sleeve; deaths are rare but occur.

Single centre; cannot represent all Egyptian practice.

Egyptian setting; not EU.

Low-quality but regionally relevant confirmation that early death is rare.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	low
Risk of bias	high
Precision of results	low
Directness	direct
Reproducibility	unknown
Consistency with the overall evidence	consistent
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable

National Egyptian registry data are lacking.